TransCelerate BioPharma (TransCelerate), a nonprofit organization dedicated to improving the health of people around the world by accelerating and simplifying clinical research, today announced the ...

The National Academies Forum on Drug Discovery, Development, and Translation convened this public workshop to examine the state of the science of drug regulation and consider approaches for enhancing ...

While the Trump administration remains unpredictable, some pharma experts are optimistic that the regulatory landscape will ...

Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...

In the global transition toward cleaner, safer, and more accountable energy systems, the most consequential work often ...

A study of more than 5,000 pages of agency documents on mifepristone over 12 years found that agency leaders almost always ...

The White House offered few details Wednesday on what Congress can expect from planned legislative recommendations for a ...

Humanized mouse models are vital for studying human gene function, but fully replacing mouse genes with complete human ...

As 2026 begins, we find ourselves reflecting on the dynamic landscape of Life Sciences and Healthcare regulations over the ...

European law firm Fieldfisher has further strengthened its regulatory offering in the Brussels office with the arrival of ...

The leaders of Chugai Pharmaceutical are tired of their company not getting its due. At the J.P. | The leaders of Chugai ...

In the high stakes world of health care and life sciences organizations, AI poses unique opportunities and challenges. Corporate Counsel and Ropes & Gray recently collaborated on a survey of this ...